You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 276 No. 21, December 4, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Epidemiologic and Microbiologic Correlates of Chlamydia trachomatis Infection in Sexual Partnerships

Thomas C. Quinn, MD, MSc; Charlotte Gaydos, DrPH; Mary Shepherd, MS; Linda Bobo, PhD; Edward W. Hook III, MD; Raphael Viscidi, MD; Anne Rompalo, MD, ScM

JAMA. 1996;276(21):1737-1742.


Abstract

Objective.
—To determine the frequency of Chlamydia trachomatis genital infection within sexual partnerships using highly sensitive polymerase chain reaction (PCR) amplification and to identify the variables that might modify transmission.

Design.
—Cross-sectional study of sexual partnerships comparing in vitro culture and PCR amplification for C trachomatis.

Setting.
—Two outpatient sexually transmitted disease clinics.

Participants.
—Four hundred ninety-four people in sexual partnerships attending sexually transmitted disease clinics.

Main Outcome Measure.
—Genital infection with C trachomatis.

Methods.
—DNA sequencing was performed to examine specific genotypes within and between partnerships. Cross-sectional analysis was performed to determine characteristics associated with concordance or discordance of infection with partnerships.

Results.
—Cultures were positive for C trachomatis in 8.5% of males and 12.9% of females (P=.03). Using PCR, more infections were identified both in males (14.2%) and in females (15.8%), and the difference in infection rates analyzed by sex was no longer significant. In 20.4% of 494 couples, at least 1 partner had PCR results positive for C trachomatis, with a concordant infection rate of 10.7%, significantly higher than the 5.5% concordant infection rate demonstrable by culture (P<.01). Male-female and female-male transmission frequencies were equal (68%). The nucleotide sequences of the major outer membrane protein gene products were identical and unique for each of 15 culture-negative, PCR-positive concordant partnerships. In concordant infections, factors associated with infection in female partners were age less than 20 years, more than 1 partner in the past 6 months, and cervical ectopy greater than 25%

Conclusions.
—Using PCR, the frequency of chlamydia transmission by infected males and females was nearly identical. The high rate of concordant infection, high frequency of infection among asymptomatic individuals, and high frequency of transmission regardless of sex underscore the importance of routine screening for chlamydia in both males and females, along with provision of treatment to all sexual partners of chlamydia-infected individuals.



Author Affiliations

From the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md (Dr Quinn); Department of Medicine, The Johns Hopkins University, Baltimore, Md (Drs Quinn, Gaydos, Bobo, Hook, Viscidi, and Rompalo and Ms Shepherd); and Baltimore City Health Department (Drs Hook and Rompalo). Dr Hook is now with the Department of Medicine, University of Alabama at Birmingham.


Footnotes

Presented in part as an abstract at the Eighth International Symposium on Human Chlamydial Infections, June 20, 1994, Chantilly, France.

Reprints: Thomas C. Quinn, MD, MSc, Division of Infectious Diseases, The Johns Hopkins University, Ross 1159, 720 Rutland Ave, Baltimore, MD 21205-2196.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study
Kretzschmar et al.
Sex. Transm. Infect. 2009;85:359-366.
ABSTRACT | FULL TEXT  

How much could a microbicide's sexually transmitted infection efficacy contribute to reducing HIV risk and the level of condom use needed to lower risk? Model estimates
Foss et al.
Sex. Transm. Infect. 2009;85:276-282.
ABSTRACT | FULL TEXT  

2009 European Guideline on the Management of Male Non-gonococcal Urethritis
Shahmanesh et al.
Int J STD AIDS 2009;20:458-464.
FULL TEXT  

Evaluation of the Rapid BioStar Optical Immunoassay for Detection of Chlamydia trachomatis in Adolescent Women
Bandea et al.
J. Clin. Microbiol. 2009;47:215-216.
ABSTRACT | FULL TEXT  

Concordance of chlamydia trachomatis infections within sexual partnerships
Rogers et al.
Sex. Transm. Infect. 2008;84:23-28.
ABSTRACT | FULL TEXT  

Asymptomatic men: should they be tested for urethritis?
Horner
Sex. Transm. Infect. 2007;83:81-84.
FULL TEXT  

Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers.
Vickerman et al.
Sex. Transm. Infect. 2006;82:403-412.
ABSTRACT | FULL TEXT  

Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis
Hu et al.
ANN INTERN MED 2004;141:501-513.
ABSTRACT | FULL TEXT  

Condom Effectiveness for Reducing Transmission of Gonorrhea and Chlamydia: The Importance of Assessing Partner Infection Status
Warner et al.
Am J Epidemiol 2004;159:242-251.
ABSTRACT | FULL TEXT  

Managing partners of people diagnosed with Chlamydia trachomatis: a comparison of two partner testing methods
Ostergaard et al.
Sex. Transm. Infect. 2003;79:358-361.
ABSTRACT | FULL TEXT  

What should we do about screening for genital chlamydia?
Low and Egger
Int J Epidemiol 2002;31:891-893.
FULL TEXT  

Risk Behaviors, Medical Care, and Chlamydial Infection Among Young Men in the United States
Ku et al.
AJPH 2002;92:1140-1143.
ABSTRACT | FULL TEXT  

Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time
Gijsen et al.
Hum Reprod 2002;17:699-703.
ABSTRACT | FULL TEXT  

Characterization of Chlamydia trachomatis omp1 Genotypes among Sexually Transmitted Disease Patients in Sweden
Jurstrand et al.
J. Clin. Microbiol. 2001;39:3915-3919.
ABSTRACT | FULL TEXT  

Comparative Model-based Analysis of Screening Programs for Chlamydia trachomatis Infections
Kretzschmar et al.
Am J Epidemiol 2001;153:90-101.
ABSTRACT | FULL TEXT  

Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks' prospective follow up study
Kjar et al.
Sex. Transm. Infect. 2000;76:169-172.
ABSTRACT | FULL TEXT  

Bile Salts: Natural Detergents for the Prevention of Sexually Transmitted Diseases
Herold et al.
Antimicrob. Agents Chemother. 1999;43:745-751.
ABSTRACT | FULL TEXT  

Chlamydia Infections and Heart Disease Linked Through Antigenic Mimicry
Bachmaier et al.
Science 1999;283:1335-1339.
ABSTRACT | FULL TEXT  

Chlamydia Infections in Female Military Recruits
Soteriades et al.
NEJM 1999;340:237-238.
FULL TEXT  

Chlamydia trachomatis Infections in Female Military Recruits
Gaydos et al.
NEJM 1998;339:739-744.
ABSTRACT | FULL TEXT  

Use of Ligase Chain Reaction with Urine versus Cervical Culture for Detection of Chlamydia trachomatis in an Asymptomatic Military Population of Pregnant and Nonpregnant Females Attending Papanicolaou Smear Clinics
Gaydos et al.
J. Clin. Microbiol. 1998;36:1300-1304.
ABSTRACT | FULL TEXT  

Men and Women Are Equally Susceptible to Chlamydia
JWatch Women's Health 1997;1997:24-24.
FULL TEXT  

HIGH RATES OF C. TRACHOMATIS INFECTION IN SEXUAL PARTNERSHIPS
JWatch General 1996;1996:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.